ANGUS, a global specialty and fine chemical company, completed the acquisition of Expression Systems, a biotechnology company. Financial terms were not disclosed. “The acquisition of Expression Systems is an important step in expanding ANGUS’ leadership position in Life Sciences beyond bio buffers into specialty cell culture media, a strategic adjacency with high customer overlap and complementary product and service offerings. The combination of ANGUS and Expression Systems further strengthens our ability to deliver value through the consistent, high-quality ingredients and services essential to all phases of bioprocessing, from early-stage biologics development to full-scale commercial production,” David Neuberger, ANGUS President and CEO.